Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients

Recently, the medications used for the severe form of the coronavirus disease-19 (COVID-19) therapy are of particular interest. In this sense, it has been supposed that anti-VEGF compounds would be good candidates in the face of “cytokine storm” and intussuscepted angiogenesis due to having an appre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahebnasagh, Adeleh, Nabavi, Seyed Mohammad, Kashani, Hamid Reza Khayat, Abdollahian, Safieh, Habtemariam, Solomon, Rezabakhsh, Aysa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519896/
https://www.ncbi.nlm.nih.gov/pubmed/34673299
http://dx.doi.org/10.1016/j.intimp.2021.108257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519896/
https://www.ncbi.nlm.nih.gov/pubmed/34673299
http://dx.doi.org/10.1016/j.intimp.2021.108257

Ejemplares similares